You're reading the free version. Trader adds the live tape and alerts.
Start tracking
HALO Exercise Disclosure
Ramsay David A · SEC Form 4 · Filed Jul 2, 2026
Exercise
Calculated transaction value
$0
Ramsay David A EVP, President, Drug Delivery
HALO
Transaction date
Jun 30, 2026
Public filing date
Jul 2, 2026
Filing lag
Filed 2 days later
HALO daily price context
Close on/before transaction
$78.27
Jun 30, 2026
First close after public filing
$80.78
Jul 6, 2026
30-day return after filing
+1.84%
Through Aug 3, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 10,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001159036-26-000096
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$423.28K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Halozyme Therapeutics, Inc. HALO | Award | Jul 1, 2026 | $0 |
| Halozyme Therapeutics, Inc. HALO | Award | Jul 1, 2026 | $0 |
| Halozyme Therapeutics, Inc. HALO Current | Exercise | Jun 30, 2026 | $0 |
| Halozyme Therapeutics, Inc. HALO | Disposition | Jun 30, 2026 | $423.28K |
| Halozyme Therapeutics, Inc. HALO | Exercise | Jun 30, 2026 | $0 |